Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

13.2K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
13.2K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

2.0K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
2.0K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

76
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
76
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

11.2K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
11.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Convenient and Versatile Route to Hydroquinolines by Inter- and Intramolecular Aza-Diels-Alder Pathways.

Angewandte Chemie (International ed. in English)·2021
Same author

Channeling drug discovery.

ChemMedChem·2012
Same author

Structure-based design and optimization of potent renin inhibitors on 5- or 7-azaindole-scaffolds.

Bioorganic & medicinal chemistry letters·2011
Same author

Structure-based optimization of potent 4- and 6-azaindole-3-carboxamides as renin inhibitors.

Bioorganic & medicinal chemistry letters·2011
Same author

Discovery and optimization of a new class of potent and non-chiral indole-3-carboxamide-based renin inhibitors.

Bioorganic & medicinal chemistry letters·2010
Same author

Structure of human G protein-coupled receptor kinase 2 in complex with the kinase inhibitor balanol.

Journal of medicinal chemistry·2010

Related Experiment Video

Updated: Mar 27, 2026

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

5.7K

Igniting Small-Molecule Drug Discovery.

Henning Steinhagen1

  • 1Grünenthal GmbH, Zieglerstraße 6, 52099, Aachen, Germany. henning.steinhagen@grunenthal.com.

Chemmedchem
|January 20, 2016
PubMed
Summary
This summary is machine-generated.

New small molecule drugs show promise for treating autoimmune and inflammatory diseases, potentially matching or exceeding biologic therapies and helping patients unresponsive to current treatments.

More Related Videos

A Manual Small Molecule Screen Approaching High-throughput Using Zebrafish Embryos
07:45

A Manual Small Molecule Screen Approaching High-throughput Using Zebrafish Embryos

Published on: November 8, 2014

18.3K
Identification of Small Molecule-binding Proteins in a Native Cellular Environment by Live-cell Photoaffinity Labeling
10:49

Identification of Small Molecule-binding Proteins in a Native Cellular Environment by Live-cell Photoaffinity Labeling

Published on: September 20, 2016

13.4K

Related Experiment Videos

Last Updated: Mar 27, 2026

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

5.7K
A Manual Small Molecule Screen Approaching High-throughput Using Zebrafish Embryos
07:45

A Manual Small Molecule Screen Approaching High-throughput Using Zebrafish Embryos

Published on: November 8, 2014

18.3K
Identification of Small Molecule-binding Proteins in a Native Cellular Environment by Live-cell Photoaffinity Labeling
10:49

Identification of Small Molecule-binding Proteins in a Native Cellular Environment by Live-cell Photoaffinity Labeling

Published on: September 20, 2016

13.4K

Area of Science:

  • Immunology
  • Medicinal Chemistry
  • Pharmacology

Background:

  • Autoimmune and inflammatory diseases represent a significant unmet medical need.
  • Current biologic therapies are effective but have limitations in efficacy and applicability.
  • Small molecules offer a novel therapeutic avenue for immune-mediated disorders.

Discussion:

  • This special issue highlights advances in small molecule therapeutics for immune-mediated inflammatory disorders.
  • Small molecules are being developed to match or exceed the efficacy of existing biologics.
  • These novel compounds may address diseases currently lacking effective treatment options.

Key Insights:

  • Medicinal chemistry is driving innovation in the development of small molecule drugs.
  • Small molecules demonstrate potential for superior efficacy compared to current biologics.
  • Therapeutic strategies targeting immune-mediated inflammatory diseases are expanding.

Outlook:

  • Small molecule drugs are poised to become a new class of medicines for autoimmune and inflammatory conditions.
  • Further research in medicinal chemistry will accelerate the development of these novel therapeutics.
  • Patients with immune-mediated inflammatory disorders may soon benefit from more effective treatment options.